A look at the gynecologic oncologist workforce - Are we meeting patient demand?

Sarah A Ackroyd1, Ya-Chen Tina Shih2, Bumyang Kim2

  • 1University of Chicago Medicine, Section of Gynecologic Oncology, 5841 S Maryland Ave, Chicago, IL 60637, USA.

Gynecologic Oncology
|August 30, 2021
PubMed
Abstract

Insights

Most US counties lack gynecologic oncologists (GO). Despite rising cancer rates, GO density remains low, leaving rural areas with high cancer incidence underserved. This highlights critical access gaps for gynecologic cancer care.

Area of Science:

  • Oncology
  • Public Health
  • Health Services Research

Background:

  • Geographic disparities in healthcare access significantly impact patient outcomes.
  • The distribution of specialized oncologists, such as gynecologic oncologists (GO), is crucial for addressing the needs of patients with gynecologic cancers.
  • Understanding the current workforce distribution relative to cancer incidence is essential for strategic planning and resource allocation.

Purpose of the Study:

  • To map the geographic distribution of gynecologic oncologists (GO) across the United States.
  • To evaluate whether the existing GO workforce adequately meets the demand for oncology services for patients with gynecologic cancers.
  • To identify underserved populations and geographic areas with high gynecologic cancer incidence but limited GO access.

Main Methods:

  • Gynecologic oncologists (GO) were identified using National Provider Identifiers (NPI).
  • County-level density of GO was calculated and compared with county-level gynecologic cancer incidence rates derived from U.S. Cancer Statistics.
  • Spatial analysis was employed to visualize the relationship between GO distribution and cancer service demand, incorporating demographic data.

Main Results:

  • In 2019, 1527 GOs were identified; 91.2% of US counties had no local GO, and 61.8% had no GO in adjacent counties.
  • Increasing gynecologic cancer rates correlated with fewer counties lacking a GO, but GO density per 100,000 women did not significantly increase with rising cancer incidence (r = -0.12, p = 0.06).
  • Women in rural areas with high gynecologic cancer rates and no local GO access were more likely to have lower median incomes and be of White race.

Conclusions:

  • A substantial number of US counties lack gynecologic oncologists, indicating significant workforce distribution challenges.
  • Despite increasing cancer incidence, the density of GOs has not proportionally increased, leading to unmet needs, particularly in rural areas.
  • Targeted initiatives for outreach and collaboration are needed to improve access to gynecologic cancer care in underserved geographic regions.